Bruker Corp. (NASDAQ:BRKR) has been given an average rating of “Hold” by the twenty-one brokerages that are currently covering the company. One research analyst has rated the stock with a sell recommendation, twelve have given a hold recommendation, five have issued a buy recommendation and one has given a strong buy recommendation to the company. The average twelve-month price objective among analysts that have issued ratings on the stock in the last year is $25.67.
A number of brokerages recently weighed in on BRKR. Barclays PLC decreased their price target on shares of Bruker Corp. from $32.00 to $30.00 and set an “overweight” rating for the company in a research report on Wednesday, August 3rd. Morgan Stanley set a $23.00 price target on shares of Bruker Corp. and gave the stock a “hold” rating in a research report on Wednesday, August 3rd. Cantor Fitzgerald decreased their price target on shares of Bruker Corp. from $34.00 to $28.00 and set a “buy” rating for the company in a research report on Wednesday, August 3rd. Janney Montgomery Scott raised shares of Bruker Corp. from a “neutral” rating to a “buy” rating and set a $28.00 price target for the company in a research report on Wednesday, August 3rd. Finally, Wells Fargo & Co. cut shares of Bruker Corp. from an “outperform” rating to a “market perform” rating in a research report on Wednesday, August 3rd.
In other Bruker Corp. news, CEO Frank H. Laukien acquired 4,500 shares of the company’s stock in a transaction that occurred on Friday, August 5th. The shares were purchased at an average price of $22.17 per share, for a total transaction of $99,765.00. Following the completion of the purchase, the chief executive officer now directly owns 37,658,733 shares in the company, valued at $834,894,110.61. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director Richard A. Packer acquired 10,000 shares of the company’s stock in a transaction that occurred on Wednesday, August 10th. The shares were acquired at an average price of $21.97 per share, for a total transaction of $219,700.00. Following the purchase, the director now owns 22,500 shares of the company’s stock, valued at $494,325. The disclosure for this purchase can be found here. Corporate insiders own 35.80% of the company’s stock.
A number of large investors have recently added to or reduced their stakes in BRKR. GSA Capital Partners LLP raised its stake in Bruker Corp. by 86.0% in the second quarter. GSA Capital Partners LLP now owns 150,990 shares of the company’s stock valued at $3,434,000 after buying an additional 69,804 shares during the period. Geode Capital Management LLC boosted its position in Bruker Corp. by 32.0% in the first quarter. Geode Capital Management LLC now owns 919,127 shares of the company’s stock valued at $25,734,000 after buying an additional 222,648 shares during the period. UBS Group AG boosted its position in Bruker Corp. by 10.0% in the first quarter. UBS Group AG now owns 76,502 shares of the company’s stock valued at $2,142,000 after buying an additional 6,967 shares during the period. Meeder Asset Management Inc. purchased a new position in Bruker Corp. during the first quarter valued at approximately $355,000. Finally, State Street Corp boosted its position in Bruker Corp. by 27.2% in the first quarter. State Street Corp now owns 1,527,696 shares of the company’s stock valued at $42,770,000 after buying an additional 326,527 shares during the period. Hedge funds and other institutional investors own 69.92% of the company’s stock.
Bruker Corp. (NASDAQ:BRKR) opened at 21.14 on Monday. The stock has a market cap of $3.41 billion, a price-to-earnings ratio of 31.84 and a beta of 0.93. The firm’s 50 day moving average price is $22.19 and its 200 day moving average price is $24.67. Bruker Corp. has a one year low of $16.99 and a one year high of $29.85.
Bruker Corp. (NASDAQ:BRKR) last announced its quarterly earnings data on Tuesday, August 2nd. The company reported $0.20 earnings per share (EPS) for the quarter, meeting the Thomson Reuters’ consensus estimate of $0.20. Bruker Corp. had a net margin of 6.86% and a return on equity of 22.66%. The company earned $371.70 million during the quarter, compared to analysts’ expectations of $409.57 million. During the same period in the previous year, the company earned $0.19 EPS. The business’s quarterly revenue was down 6.1% compared to the same quarter last year. Equities analysts forecast that Bruker Corp. will post $1.00 earnings per share for the current year.
The firm also recently disclosed a quarterly dividend, which was paid on Friday, September 23rd. Investors of record on Tuesday, September 6th were paid a dividend of $0.04 per share. The ex-dividend date of this dividend was Thursday, September 1st. This represents a $0.16 annualized dividend and a yield of 0.76%. Bruker Corp.’s dividend payout ratio (DPR) is 24.24%.
About Bruker Corp.
Bruker Corporation is a designer and manufacturer of scientific instruments, and analytical and diagnostic solutions. The Company’s operating segments include the Bruker BioSpin Group; the Bruker Chemicals, Applied Markets, Life Science, In-Vitro Diagnostics, Detection (CALID) Group; the Bruker Nano Group, and the Bruker Energy & Supercon Technologies (BEST) Segment.
Receive News & Ratings for Bruker Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bruker Corp. and related companies with MarketBeat.com's FREE daily email newsletter.